Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
on behalf of the
, PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
, PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
Research output: Contribution to journal › Article › Research › peer-review
30Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial'. Together they form a unique fingerprint.